Size-dependent cellular uptake and TLR4 attenuation by gold nanoparticles in lung adenocarcinoma cells.
A549 Cells
Adenocarcinoma of Lung
/ drug therapy
Gold
/ chemistry
Humans
Immunologic Factors
/ metabolism
Interleukin-1beta
/ metabolism
Interleukin-6
/ metabolism
Lung Neoplasms
/ drug therapy
Metal Nanoparticles
/ chemistry
Signal Transduction
Toll-Like Receptor 4
/ metabolism
Toll-Like Receptor 9
/ metabolism
A549 cells
GNPs
IL-1β
IL-6
RNI
ROS
TLR4
TNF-α
Journal
Nanomedicine (London, England)
ISSN: 1748-6963
Titre abrégé: Nanomedicine (Lond)
Pays: England
ID NLM: 101278111
Informations de publication
Date de publication:
02 2019
02 2019
Historique:
pubmed:
19
1
2019
medline:
30
4
2019
entrez:
19
1
2019
Statut:
ppublish
Résumé
To elucidate uptake mechanisms and immunomodulatory potential of differently sized gold nanoparticles (GNPs) in lung adenocarcinoma cells (A549) to enable their use as an adjunct therapy for treating inflammation-linked lung cancer. Internalization of the synthesized (5, 15 and 30 nm) GNPs by various endocytosis pathways was determined. Immunomodulatory mechanisms induced by differently sized GNPs in A549 cells in the presence of TLR4 and TLR9 ligands were evaluated. GNPs were size-dependently internalized efficiently by A549 cells. Various sized GNPs downregulated the expression of proinflammatory signaling molecules (5 nm most potent). Mechanistically, 5-nm GNPs attenuated TLR4 signaling by downregulating TLR4 expression in A549 cells. Our study suggests the use of immunomodulatory GNPs as an adjunct therapy against inflammation-linked lung cancer.
Identifiants
pubmed: 30657415
doi: 10.2217/nnm-2018-0266
doi:
Substances chimiques
Immunologic Factors
0
Interleukin-1beta
0
Interleukin-6
0
Toll-Like Receptor 4
0
Toll-Like Receptor 9
0
Gold
7440-57-5
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM